Related content

The free/total prostate-specific antigen ratio (%fPSA) is the best predictor of tumor involvement in the radical prostatectomy specimen among men with an elevated PSA

By Grossklaus D.J.   Smith J.A.   Shappell S.B.   Coffey C.S.   Chang S.S.   Cookson M.S.  

Urologic Oncology: Seminars and Original Investigations, Vol. 7, Iss. 5, 2002-09 ,pp. : 195-198

Elsevier

Access to resources Recommend Favorite

Prostate cancer in Saskatchewan Canada, before and during the PSA era

By Skarsgard D.  

Cancer Causes and Control, Vol. 11, Iss. 1, 2000-01 ,pp. : 79-88

Springer Publishing Company

Access to resources Recommend Favorite

Efficacy of weekly paclitaxel in patients with advanced gastric cancer refractory to docetaxel-based chemotherapy

By Ando Takayuki   Hosokawa Ayumu   Kajiura Shinya   Itaya Yuko   Ueda Akira   Fujinami Haruka   Nishikawa Jun   Kobayashi Takashi   Horikawa Naoki   Tsukioka Yuji   Yabushita Kazuhisa   Note Masayuki   Ogawa Kohei   Sugiyama Toshiro  

Gastric Cancer, Vol. 15, Iss. 4, 2012-10 ,pp. : 427-432

Springer Publishing Company

Access to resources Recommend Favorite

Short-term androgen deprivation and PSA doubling time: their association and relationship to disease progression after radiation therapy for prostate cancer

By Hanlon A.L.   Horwitz E.M.   Hanks G.E.   Pollack A.  

International Journal of Radiation Oncology*Biology*Physics, Vol. 58, Iss. 1, 2004-01 ,pp. : 43-52

Elsevier

Access to resources Recommend Favorite

Introduction to Department of Defense Center for Prostate Disease Research Multicenter National Prostate Cancer Database, and analysis of changes in the PSA-era

By Sun L.   Gancarczyk K.   Paquette E.L.   McLeod D.G.   Kane C.   Kusuda L.   Lance R.   Herring J.   Foley J.   Baldwin D.   Bishoff J.T.   Soderdahl D.   Wu H.   Xu L.   Moul J.W.  

Urologic Oncology: Seminars and Original Investigations, Vol. 6, Iss. 5, 2001-09 ,pp. : 203-209

Elsevier

Access to resources Recommend Favorite